Royal Bank Of Canada Cuts Amrize (NYSE:AMRZ) Price Target to $60.00

Key Points

• Royal Bank of Canada cut Amrize's price target to $60 (from $61) and kept a "sector perform" rating, implying roughly a 12.78% upside from the prior close.
• Analyst consensus is a "Moderate Buy" with an average price target of $65; across analysts there are 1 Strong Buy, 11 Buy and 5 Hold ratings.
• Amrize missed quarterly EPS (-$0.16 vs. -$0.14) while revenue rose 4.7% to $2.18B; the stock traded near $53.20 and insiders bought shares (77,834 shares acquired in the last 90 days).

Amrize (NYSE:AMRZ - Get Free Report) had its price target lowered by stock analysts at Royal Bank Of Canada from $61.00 to $60.00 in a report issued on Friday,Benzinga reports. The firm currently has a "sector perform" rating on the stock. Royal Bank Of Canada's price target indicates a potential upside of 12.78% from the stock's previous close.

AMRZ has been the subject of several other research reports. UBS Group upped their price objective on shares of Amrize from $53.00 to $57.00 and gave the company a "neutral" rating in a research note on Thursday, January 8th. Wells Fargo & Company dropped their price target on shares of Amrize from $66.00 to $65.00 and set an "overweight" rating for the company in a research note on Wednesday, April 15th. Weiss Ratings raised shares of Amrize from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, March 18th. Citigroup increased their price target on shares of Amrize from $63.00 to $67.00 and gave the company a "buy" rating in a research note on Thursday, January 8th. Finally, Oppenheimer set a $68.00 price target on shares of Amrize in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $65.00.

Amrize Price Performance

Shares of AMRZ traded down $0.58 during mid-day trading on Friday, hitting $53.20. 1,063,944 shares of the company were exchanged, compared to its average volume of 3,208,296. Amrize has a 1-year low of $44.12 and a 1-year high of $65.94. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64. The company has a 50 day moving average of $57.86 and a 200-day moving average of $54.87. The stock has a market cap of $29.42 billion and a price-to-earnings ratio of 25.47.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.88%. The business had revenue of $2.18 billion for the quarter. Amrize's revenue was up 4.7% on a year-over-year basis. Analysts expect that Amrize will post 2.76 EPS for the current fiscal year.

Insider Transactions at Amrize

In related news, CFO Ian A. Johnston acquired 4,250 shares of the firm's stock in a transaction dated Tuesday, March 10th. The shares were purchased at an average cost of $58.94 per share, for a total transaction of $250,495.00. Following the acquisition, the chief financial officer owned 25,110 shares in the company, valued at $1,479,983.40. The trade was a 20.37% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mario Gross acquired 3,200 shares of the firm's stock in a transaction dated Friday, March 13th. The stock was bought at an average price of $55.29 per share, for a total transaction of $176,928.00. Following the completion of the acquisition, the insider owned 30,947 shares in the company, valued at approximately $1,711,059.63. The trade was a 11.53% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders acquired 77,834 shares of company stock worth $4,511,344. 0.54% of the stock is owned by company insiders.

Institutional Investors Weigh In On Amrize

A number of hedge funds have recently added to or reduced their stakes in AMRZ. Geode Capital Management LLC acquired a new stake in Amrize during the 2nd quarter worth approximately $265,000. M&T Bank Corp acquired a new stake in shares of Amrize in the 2nd quarter valued at $205,000. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Amrize in the 2nd quarter valued at $3,870,000. Gabelli Funds LLC acquired a new stake in Amrize during the 2nd quarter worth $1,083,000. Finally, AXA S.A. acquired a new stake in Amrize during the 2nd quarter worth $1,065,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.